MedTrace Logo

Evaluation of a New Strategy for the Diagnosis of Peroxisomal Diseases

NCT03163771 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 8

Last updated 2025-12-05

No results posted yet for this study

Summary

The principal aim of the study is to avoid the diagnostic wanderings of patients suffering from a peroxisomal disorder. For this purpose, a new diagnostic strategy is proposed. It rests on functional metabolic explorations and gene studies directly connected to a first-line enlarged physico-chemical detection of metabolites from peroxisomal origin in clinically suspect patients.

Conditions

  • Peroxisomal Disorders
  • Diagnoses Disease

Sponsors & Collaborators

  • Ministry of Health, France

    collaborator OTHER_GOV

  • University Hospital, Lille

    lead OTHER

Principal Investigators

  • Joseph VAMECQ, MD · University Hospital, Lille

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-18
Primary Completion
2022-08-15
Completion
2022-08-15

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03163771 on ClinicalTrials.gov